In addition, it was found that NGF participates in the neuroendocrine differentiation of prostate cancer since the inhibition or knockdown of NGF prevents neuroendocrine differentiation through a mechanism dependent on the cholinergic muscarinic receptor 4 (CHRM4) [51]. This evidence concerns the gene CHRM4 and prostate cancer.